Related Experiment Video
Updated: Mar 6, 2026

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
Published on: June 28, 2019
[Revascularization in Stable Ischemic Heart Disease: Whether to Change the Approach?]
L L Bershtein1, N O Katamadze1, A E Golovina1
1North-Western State Medical University named after I.I. Mechnikov, St.-Petersburg, Russia.
Insights
Current guidelines for stable ischemic heart disease (IHD) recommend coronary revascularization, but evidence is outdated. New trials suggest optimal medical therapy (OMT) alone may suffice, necessitating further research.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Trials
Background:
- Current guidelines for stable ischemic heart disease (IHD) recommend coronary revascularization based on symptoms, anatomy, and stress test results.
- However, the evidence supporting these recommendations stems from older studies with different medical therapies and revascularization techniques.
- Many conclusions are derived from observational studies and subanalyses, limiting their methodological reliability.
Purpose of the Study:
- To critically analyze the evidence base for current coronary revascularization guidelines in stable IHD.
- To review contemporary optimal medical therapy (OMT) components for stable IHD.
- To discuss the necessity of large-scale randomized clinical trials comparing OMT versus OMT plus revascularization.
Main Methods:
- Systematic review of existing literature and guidelines on stable IHD.
- Analysis of data from historical and recent clinical trials.
- Evaluation of contemporary OMT strategies.
Main Results:
- Evidence supporting current revascularization guidelines is largely based on outdated data and methodologically limited studies.
- Recent trials show conflicting results compared to older studies.
- Contradictory opinions exist within the cardiology community regarding revascularization indications.
Conclusions:
- The evidence base for current stable IHD revascularization guidelines requires re-evaluation due to outdated data and methodological limitations.
- There is a pressing need for large-scale randomized clinical trials to compare OMT with OMT plus revascularization in stable IHD patients.
Abstract:
Current international guidelines on stable ischemic heart disease (IHD) state that coronary revascularization is indicated in cases of: limiting ischemic symptoms while on optimal medical therapy (OMT); high risk coronary anatomy; high risk stress test result. At the same time, many results supporting these conclusions were obtained in relatively old studies, conducted when the approaches to medical therapy and revascularization techniques differed greatly from contemporary practice. Many of the conclusions have been based on data from observational studies and subanalyses of randomized clinical trials, therefore methodologically are not sufficiently reliable. Moreover, the results of more modern trials do not coincide with the older. This situation has generated contradictory opinions on the indications for coronary revascularization in patients with IHD in the cardiology community. This review contains analysis of the evidence base of current revascularization guidelines, data on components of OMT, and discussion of the need for large-scale randomized clinical trial comparing effectiveness of OMT and OMT+revascularization in patients with stable IHD.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care

